Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
Dinsdale
Claire
C
Department of Elderly Medicine, Morriston Hospital, Morriston, Swansea SA6 6NL, UK.
Wani
Mushtaq
M
Steward
John
J
O'Mahony
M Sinead
MS
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced / Q000209:etiology*; D008297:Male; D051437:Renal Insufficiency / Q000209:etiology; D012189:Retrospective Studies; D013148:Spironolactone / Q000009:adverse effects / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D013148:Spironolactone